Chemical Works of Gedeon Richter (BUD:RICHTER) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Chemical Works of Gedeon Richter's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Chemical Works of Gedeon Richter's long-term debt to total assets ratio increased from Dec. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Chemical Works of Gedeon Richter is progressively becoming more dependent on debt to grow their business.

Chemical Works of Gedeon Richter LT-Debt-to-Total-Asset Historical Data

The historical data trend for Chemical Works of Gedeon Richter's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter LT-Debt-to-Total-Asset Chart

Chemical Works of Gedeon Richter Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.02

0.01

Chemical Works of Gedeon Richter Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Chemical Works of Gedeon Richter LT-Debt-to-Total-Asset Calculation

Chemical Works of Gedeon Richter's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	18457	/	1361217
	=	0.01

Chemical Works of Gedeon Richter's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	18457	/	1361217
	=	0.01

Chemical Works of Gedeon Richter (BUD:RICHTER) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Chemical Works of Gedeon Richter LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

RGEDF:USA GEDSF:USA 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines